MNMark NelsonMD, MBBS, FRCPSlidesetHIVBelem HIV Clinical Forum 2019Switching to INSTIs Based Treatment in Viral Suppressed Patients - Mark Nelson, MDView Slideset
SlidesetHIVBelem HIV Clinical Forum 2019Clinical Case - Maria do Perpetuo Socorro Costa Correa, MDView Slideset
MNMark NelsonMD, MBBS, FRCPSlidesetHIVBelem HIV Clinical Forum 2019Clinical Management of HIV-TB Co-Infected Patients - Mark Nelson, MDView Slideset
MSMauro SchechterMD, PhDSlidesetHIVBelem HIV Clinical Forum 2019Role of INSTIs in Prevention - Mauro Schechter, MD, PhDView Slideset
SWSharon WalmsleyCM, MD, FRCPCSlidesetHIVBelem HIV Clinical Forum 2019INSTIs Use in Women at Child-Bearing Age - NTD Risks - Sharon Walmsley, FRCPC, MD, MSCView Slideset
RDRicardo DiazMDSlidesetHIVBelem HIV Clinical Forum 2019Experience with Dolutegravir in First Line in Brazil - Ricardo Diaz, MDView Slideset
CBCharles BoucherMD, PhDSlidesetHIVBelem HIV Clinical Forum 2019Resistance Considerations When Choosing INSTIs - Charles Boucher, MD, PhDView Slideset
SlidesetHIVBelem HIV Clinical Forum 2019Clinical Case - Gustavo Albino Pinto Magalhães, MD, PhDView Slideset
CFCharles FlexnerMDSlidesetHIVBelem HIV Clinical Forum 2019Pharmacology Considerations When Choosing INSTIs - Charles Flexner, MDView Slideset
PCPedro CahnMD, PhDSlidesetHIVBelem HIV Clinical Forum 2019Simplification of Drug Regimens - Pedro Cahn, MD, PhDView Slideset
OSOmar SuedMSc, MD, PhDSlidesetHIVArgentinian HIV Clinical Forum 2019INSTIs Use in TB Coinfected Patients - Omar Sued, MSc, MD, PhDView Slideset
SlidesetHIVArgentinian HIV Clinical Forum 2019INSTIs Toxicity, Myths and Reality - Gustavo Lopardo, MDView Slideset
